The Health Insurance Organisation is clearing its list of General Healthcare System beneficiaries receiving diabetes injection Ozempic, aiming to restrict the drug exclusively to genuine diabetic patients through the system. The organisation has notified doctors in relevant specialities, requesting they submit applications on behalf of their patients by 31st August 2025. The injectable diabetes preparation … Continue reading HIO moves to restrict Ozempic access to diabetic patients only